Regulatory challenges with biosimilars: an update from 20 countries.
- DOI
- 10.1111/nyas.14522
- Published
- 2021 May
- Container
- Annals of the New York Academy of Sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/nyas.14522,
title = {Regulatory challenges with biosimilars: an update from 20 countries.},
author = {Kang HN and Thorpe R and Knezevic I and Casas Levano M and Chilufya MB and Chirachanakul P and Chua HM and Dalili D and Foo F and Gao K and Habahbeh S and Hamel H and Kim GH and Perez Rodriguez V and Putri DE and Rodgers J and Savkina M and Semeniuk O and Srivastava S and Tavares Neto J and Wadhwa M and Yamaguchi T},
year = {2021},
journal = {Annals of the New York Academy of Sciences},
doi = {10.1111/nyas.14522},
url = {https://doi.org/10.1111/nyas.14522}
}RIS
TY - JOUR TI - Regulatory challenges with biosimilars: an update from 20 countries. AU - Kang HN AU - Thorpe R AU - Knezevic I AU - Casas Levano M AU - Chilufya MB AU - Chirachanakul P AU - Chua HM AU - Dalili D AU - Foo F AU - Gao K AU - Habahbeh S AU - Hamel H AU - Kim GH AU - Perez Rodriguez V AU - Putri DE AU - Rodgers J AU - Savkina M AU - Semeniuk O AU - Srivastava S AU - Tavares Neto J AU - Wadhwa M AU - Yamaguchi T PY - 2021 JO - Annals of the New York Academy of Sciences DO - 10.1111/nyas.14522 UR - https://doi.org/10.1111/nyas.14522 ER -
APA
HN, K., R, T., I, K., M, C. L., MB, C., P, C., HM, C., D, D., F, F., K, G., S, H., H, H., GH, K., V, P. R., DE, P., J, R., M, S., O, S., S, S., J, T. N., M, W., & T, Y. (2021). Regulatory challenges with biosimilars: an update from 20 countries.. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.14522
Source records
- pubmed · retrieved 2026-09-25T22:49:24.737Z